NantHealth Inc (NASDAQ:NH)s stock price rose 2.6% on Monday . The stock traded as high as $1.17 and last traded at $1.20, approximately 1,600 shares changed hands during mid-day trading. A decline of 99% from the average daily volume of 170,258 shares. The stock had previously closed at $1.17.

NH has been the topic of several analyst reports. ValuEngine raised shares of NantHealth from a sell rating to a hold rating in a report on Tuesday, November 19th. Cowen set a $1.00 target price on shares of NantHealth and gave the company a buy rating in a report on Monday, August 26th. Finally, Zacks Investment Research downgraded shares of NantHealth from a buy rating to a hold rating in a report on Thursday, August 15th.

The firm has a market cap of $118.36 million, a PE ratio of -0.69 and a beta of 1.21. The companys fifty day moving average price is $0.76 and its two-hundred day moving average price is $0.64.

NantHealth (NASDAQ:NH) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.07) by ($0.08). NantHealth had a negative net margin of 105.82% and a negative return on equity of 10,106.10%. The company had revenue of $22.36 million during the quarter, compared to analyst estimates of $23.40 million. As a group, equities analysts predict that NantHealth Inc will post -0.46 EPS for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in NH. Paloma Partners Management Co lifted its stake in shares of NantHealth by 436.1% in the second quarter. Paloma Partners Management Co now owns 91,100 shares of the companys stock valued at $48,000 after purchasing an additional 74,108 shares during the period. Miracle Mile Advisors LLC lifted its stake in shares of NantHealth by 154.2% in the second quarter. Miracle Mile Advisors LLC now owns 75,000 shares of the companys stock valued at $39,000 after purchasing an additional 45,500 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in shares of NantHealth by 778.8% in the third quarter. Tower Research Capital LLC TRC now owns 45,988 shares of the companys stock valued at $33,000 after purchasing an additional 40,755 shares during the period. Hedge funds and other institutional investors own 3.27% of the companys stock.

About NantHealth (NASDAQ:NH)

NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice.

Featured Article: Options Trading Understanding Strike Price

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.

More:

NantHealth (NASDAQ:NH) Stock Price Up 2.6% - Riverton Roll